Marc Robillard

Company: Tagworks Pharmaceuticals

Job title: Chief Executive Officer

Seminars:

A Version of ADCs: Antibody Formats Amenable to Improving PK/PD of Radiopharmaceuticals 1:45 pm

Discussing differences in the mechanisms of action for an ADC versus radiopharmaceutical Exploring different antibody fragments to target and deliver radioactivity to the tumor and generate a good half-life locally Insights into novel click cleavable ADCs for delivery of radiotherapeuticsRead more

day: Day One - PM

Click-Cleavable ADCs 3:40 pm

Expanding the therapeutic window and application scope of ADCs through in vivo click release chemistry, to increase efficacy and decrease toxicity Updates on TGW101, targeting TAG72, inaccessible with current ADC technologies Insights to radiotherapeutics programs to dateRead more

day: Day One - PM